Peer Review History
| Original SubmissionMay 21, 2020 |
|---|
|
PONE-D-20-13577 Evaluation of an integrated intervention to reduce psychological distress and intimate partner violence in refugees: Results from the Nguvu cluster randomized feasibility trial PLOS ONE Dear Dr. Greene, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 12 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Nancy Beam, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. In your revised cover letter, please address the following prompts: a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see http://www.bmj.com/content/340/bmj.c181.long for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. We will update your Data Availability statement on your behalf to reflect the information you provide. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Congratulations to the authors for tackling a complex and difficult topic in an extremely challenging environment. It is a Herculean task but one worth doing. The study is the result of careful published developmental work and was carefully implemented in the very constraining context. This reviewer appreciated the clarity and honesty of the discussion section. I think the lessons from the study are important for others seeking to adapt the methods to their own studies. However, I think that more needs to be explained and the lessons made clearer. The authors have addressed several of the major limitations of this study in their discussion, but I have concerns that I think need addressing before the article should be published. 1. The study is described as a feasibility cluster randomised trial, but it is not sufficiently well described. It is as if it is individually randomised. a. Please provide a table describing the characteristics of the clusters. (You yourselves have described the differentiation between trainers inside those clusters). b. The flow chart should begin with eligible clusters, followed by women. Please add to your flowchart detail of how many women were randomised into each group, following the table with cluster characteristics and then detail of any cluster dropouts as well as those individual women in each cluster 2. Pls include a summary of the power calculation, effect size sought and ICC in your methods to reach n=400 outlined in your protocol prior to statistical analyses. 3. Please alter references for the CTS. CTS 1 has been widely criticised. ORC Macro is a website for an American development aid organisation that requires login or registration to access. Please provide a more accessible reference or cite CTS2 if that is the adaptation. 4. P.8 (under population) you add screening questions about phys/sex violence (probably better in procedures /recruitment section. P.11 you state measurement of psych/phys & sexual violence. How was psychological violence measured? 5. Statistical analyses. What do you mean by intent-to-treat? Do you mean inclusion of the 275 completed cases by arm? 6. You did very well with maintaining the sample 88%, but you did have one in ten women dropout. Even though they were (as always) the more severe, how was missingness accounted for? Did you use any imputation? 7. How was missingness taken into account for composite variables? 8. Minor points: a. Please reference your measures in the first section as well as later on. b. P.6. line98 – Please explain or give a reference for ‘qualitative free listing’ also for a ‘refugee incentive worker’ for those unfamiliar with these settings c. Please add numbers of your ethics review boards d. Please add n= at the top of tables five and table six. e. Where is Table 4? You may need to relabel f. P.20 onwards , please give number/denominator and %s. Reviewer #2: This paper presents a “feasibility” seeking cluster-randomized trial (CRT). As per the convention, no sample size justification is provided. Albeit, the paper fall short on several areas which I will focus bellow. 1. Description of randomization is either incomplete or missing. This is very important as the randomization in CRT is much more challenging. Please describe clearly randomization scheme. A feasibility aspect of randomization needs to be discussed. 2. Why CRT is chosen as compared to simple RCT also need to be discussed. For example what consist of a cluster unit and why individual randomization to one of the arm cannot be done should be discussed. 3. Report Intra-Class-Correlation as that is useful for a future powered trial. 4. Following the notion of feasibility trial all results of significance and p-value must be removed. Note, a pilot or feasibility trial is not efficacy establishing trial and as a result, no claim of significance can be made. Confidence intervals are fine as well as text indicating the direction of effect size. 5. While no Sample size justification is not necessary I wonder how authors came up with n=311!! How many clusters per arm is there? Note, this is pretty large sample size for a feasibility study which typically has much restricted sample size. This issue needs clarification. 6. It is not clear whether authors encountered any missing data and how it is handled or plans to be handled in the powered future trial. Also explain how the data will be made available as per PLOS-policy. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
PONE-D-20-13577R1 Evaluation of an integrated intervention to reduce psychological distress and intimate partner violence in refugees: Results from the Nguvu cluster randomized feasibility trial PLOS ONE Dear Dr. Greene, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Thank you for this resubmission. I apologize about the delay in delivering feedback as it was necessary to assign a new academic editor. The reviewers note that many of their original comments and suggestions were attended to with Revision #1; however, they still note that some minor revisions are necessary before publication. We look forward to receiving this second revision. Please submit your revised manuscript by Apr 22 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Michelle L. Munro-Kramer, PhD, CNM, FNP-BC Academic Editor PLOS ONE Journal Requirements: Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: (No Response) Reviewer #3: (No Response) Reviewer #4: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Partly Reviewer #4: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #3: No Reviewer #4: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #3: Yes Reviewer #4: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes Reviewer #4: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1.2 Thank you for revising the flowchart table and recruitment description. Your description of the design of the study is much clearer and your recruitment strategy also. 1.3 Thank you for adding cluster characteristics to Table 1. Please can you add an indication of what is in parentheses in the table. I might assume SD, but it is helpful to know. It was interesting to see the differences that looked quite significant between clusters. OK 1.4. Re the flowchart, it would be helpful however, to have the number of eligible women in the I and C clusters to see how balanced they began. However, please include those missing for the primary outcome analysis – 311 to 275 1.5 I am now very confused about your power calculation. In the original paper you state you require 400 to achieve a moderate to small effect size. This reviewer thinks that for a paper to be useful, the power calculation should be verifiable and the description clear. So, you calculated 200 for each study condition (do you mean IPV and mental health or the two MH measures?). What was the effect size examined for each condition and is the MH effect clinically meaningful? Where did the relatively small ICCs come from - please provide a reference. What is impact on power of only having 43 groups rather than 63 clusters for your analysis? This response needs further revision, but I am glad you know cite your ICCs for future studies 1.6 Refs 25-27 are your AAS and mental health measures. Fortunately, in your text, you cite the correct numbers, but for references online, you should include the website and date accessed. Please make 29 and 30 more accessible please. These are international organisations with websites, and it is unclear where those you cite can be found. Needs correction 1.7 As the DHS measures are one of your primary outcomes, it would be useful to know which questions you used. The WHO MCS has many questions, as does the DHS. Which ones did you use, please add? If space is an issue, drop the AAS screening questions, as there are few of these - especially as IPV (DHS) were far more prevalent than your MH measures. 1.8 OK- most people use complete case analysis for ITT. OK 1.9 Good response. OK 1.10 OK thanks 1.11 OK 1.12 Definition helpful OK 1.13 IRB numbers added thx OK 1.14 It is important to see the n in your tables as it is smaller than the original sample. OK 1.15 Renumbered OK 1.16 OK Discussion. Are the MH differences found clinically significant? Please comment. Reviewer #3: The manuscript entitled ’Evaluation of an integrated intervention to reduce psychological distress and intimate partner violence in refugees: Results from the Nguvu cluster randomized feasibility trial’ with the aim to examine the relevance, acceptability, and feasibility of a multi-sectoral integrated violence and mental health-focused intervention (Nguvu). This is an interesting study. The manuscript can be further improved based on the comments below. Materials and Methods Line 160, information on allocation of concealment, blinding, person who performed the randomization to be stated. The language version used in the assessment/questionnaires to be stated. Line 193-194, type of mental health outcomes, effect size figures, alpha to be stated and reference(s) to be cited. Line 221-228, more information to be provided for the usual care group i.e what is happening between baseline to 9 weeks after receiving information at baseline. For the low education level subjects, were there any difficulties in understanding the content of the study/questionnaires or questions asked? Statistical analyses Line 263, statistical tests/approach for each analysis to be clearly stated including statistical software which was used to derive the OR, 95%CI, effect size, correlation, ICC, regression analysis output. Line 271, the sentence ‘To examine….’ to be placed in a new paragraph. Line 274, the sentence requires revision. Results Table 1, the word 95% CI in the OR column to be removed. Line 387-395, 401-403, 418-433 to be presented in table form. Table 4, the word per protocol analysis to be omitted from model 4 and place on top of the first row along with intent to treat analysis. In the title, intent to treat and per protocol analysis to be stated. For the variable children, which variable children was used to be clearly stated/denoted. For the convenient of reader, ensure the sequence of results presentation is aligned to the sequence stated in the statistical analysis section. Figure 1, some figures not tally. References to conform with the journal format. Reviewer #4: This is a paper of a feasibility trial of a mental health and IPV intervention with refugees in Tanzania. The authors were responsive to comments of the previous reviewer. The authors did an excellent job describing the results of the trial. It would be helpful to add more information to the introduction to frame the significance and innovation of this intervention for this particular population and the theoretical framework that motivated the intervention. The paper would also benefit from adding some information to the methods section on the description of the intervention itself, so that the statements in the discussion are more easily interpretable. The discussion would benefit from describing what the researchers learned about conducting IPV/mental health interventions with refugees and what recommendations they have for future intervention research with refugees. INTRODUCTION Intro needs to discuss background on what are the specific mental health issues and IPV needs among refugees. How do refugees’ rates of mental health and IPV compare to the general population in Tanzania or DRC? Have there been other interventions that have been tried with the same population? What did they find? How does this intervention compare with those? p. 5, lines 82-85: This sentence could benefit from more clarity. Who is pathologizing women? Why do we need a critical feminist analysis? Any citations for this analysis and how it should be applied here?: “Studies that indicate poor mental health in the survivor may lead to increased risk for IPV require a critical feminist and human rights analysis to avoid pathologizing and blaming women for the crime of male-perpetrated violence in relationships.” p. 5, line 88: women with mental disorders related to IPV – what are these specific disorders? p. 6, lines 96-97: Need rationale for why this intervention is especially necessary in low-resource, refugee settings. The third paragraph in the Intro (page 6) is about the formative research that lead to the Nguvu intervention. This feels like it should go in the Methods. P. 6-7, lines 111-117: this is one very long sentence that is hard to follow. It should be broken up for readability. p. 7: lines 126-130 This info is unclear and needs better explanation/elaboration for the reader to understand the importance of the study context, the multi-sectoral nature of the intervention… . METHODS Suggest new paragraph at line 169: “Eligible participants were adult (18+ years) female Congolese refugees living in…” lines 187-189, this sentence is long and could use some editing to make it more succinct: “Women recruited from women’s groups randomized to Nguvu were enrolled in the intervention, whereas none of the women who were recruited from women’s groups randomized to the control received the intervention. Was there a minimum threshold of number of members per group, in order to have the group included in the study? (for example, if only 2 members of a group participated in the study, did you retain the group in the study?) Were all members of a group allocated to the same condition? It would be useful to provide a short summary of the intervention in the Methods section. The authors provide citations for the intervention description, but given that this is a paper on the outcomes of the intervention, it would be useful to know some key details about the intervention here. For example, were the sessions delivered in person? Were the sessions designed to address some group-level variables, such as social cohesion? It is important to have these things in mind when evaluating the results. Lines 225-226: What types of legal services were available to the women? What usual care services were available? Lines 243-245: Why was IPV captured over the past two weeks and not the past month? Lines 249-251: What is the intervention cohort study? What is the validation study? Are these the same thing? Lines 255-257: How was acknowledging the sensitivity of the sexual violence questions supposed to improve the test-retest reliability? The connection between these two things is unclear. Lines 269-270: Please explain what you mean by “We examined sensitivity to change in IPV… by calculating the change in primary and secondary outcomes”. What statistical analysis were you performing to examine “sensitivity”? Lines 300-301: It sounds a bit odd to refer to documenting adverse events as an indicator of acceptability. Adverse events, on the face of it, don’t seem like the only variable for whether participants find the intervention acceptable. Perhaps framing adverse events as a safety indicator related to acceptability would help. Lines 308-309: What types of deviations to the study protocol were recorded? Please describe somewhere in the measures section: what is the significance of the participants’ resettlement process? What does this variable indicate? RESULTS Given that there were groups that were as small as 3 people, did that interfere with the way the intervention was intended? Did the analysis control for group size? Lines 345-347: Why is the word “appeared” used in this sentence; was it higher or not? Were these means not compared statistically? If not, why?: “The proportion of women who were not married, but living with their partner, more highly educated, and literate appeared to be higher in women’s groups allocated to the Nguvu condition…” Table 1: - This table packs in a lot of information and it is a bit difficult to read. I suggest reducing the amount of text, if possible. For example, under the Resettlement category, I think it is not necessary to repeat “Respondent/household” for each value listed. - Are the individual n (%) reported? There is text saying that they are listed for each category but I’m not sure which number they refer to. Can you just add a column? For example, “Education level, cluster mean %(SD), individual n(%)” Table 2 is a nice summary of findings. Table 3 – could you move the M(SD) and n(%) to column headings so that you don’t have to repeat them every row? DISCUSSION It would be helpful in the discussion to return to the very important issue of how this kind of an intervention should work in a refugee setting. Are there specific barriers or characteristics in the refugee setting that must be addressed in future interventions? What did you learn about this particular setting from this intervention? You mention several key components of the intervention (task sharing, Cognitive Processing Therapy) that are mentioned for the first time in the discussion. It is hard to interpret these statements without reading some background on these components earlier in the paper. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #3: No Reviewer #4: Yes: Thespina J Yamanis [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 2 |
|
Evaluation of an integrated intervention to reduce psychological distress and intimate partner violence in refugees: Results from the Nguvu cluster randomized feasibility trial PONE-D-20-13577R2 Dear Dr. Greene, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Michelle L. Munro-Kramer, PhD, CNM, FNP-BC Academic Editor PLOS ONE Additional Editor Comments (optional): Thank you for the thoughtful edits in response to the reviewer comments. We are happy to accept this manuscript for publication. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-20-13577R2 Evaluation of an integrated intervention to reduce psychological distress and intimate partner violence in refugees: Results from the Nguvu cluster randomized feasibility trial Dear Dr. Greene: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Michelle L. Munro-Kramer Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .